Oral Mucositis Market | Oral Mucositis Treatment Algorithm and Emerging Therapy Assessment

You may have side effects from chemotherapy or radiation therapy that you don’t need in your life. One of the most prevalent side effects of these treatments is mucositis. It can also happen to patients who have compromised immune systems due to noncancerous illnesses.

Oral Mucositis is an inflammation of the tissues lining the inside of your mouth, which is part of your mucosa membrane. It is painful and can be debilitating. According to a study published in the journal Translational Oncology, mucositis affects 40 percent of chemo patients and up to 100 percent of patients with neck and head tumors.

Oral Mucositis Causes

Cancer treatments are the leading cause of Oral Mucositis. High dose chemotherapy and localized high dose radiation therapy to the head and neck are the main risk factors for oral mucositis. The cells in the body’s mucous membranes break rapidly, similar to cancer cells.

Several factors can also develop the causes of Oral Mucositis. Such as:

● Chewing Or Smoking Tobacco, And Drinking Alcohol.

● Experiencing Dry Mouth,

● Being Dehydrated,

● Having A Chronic Condition (Kidney Disease Or Diabetes),

● Having An Unusually Low Body Mass Index,

● Having Poor Oral Health,

Oral Mucositis Signs & Symptoms

Commonly observed signs and symptoms of oral mucositis are;

● Red or swollen mouth and gums

● Blood in the mouth

● Sores mouth, gums, or tongue

● Pain in the throat

● Difficulty in swallowing

● Feeling of dryness, mild burning;

● Soft, whitish patches in the mouth or on the tongue

● Increased mucus saliva in the mouth.

Oral Mucositis Treatment

There are several oral mucositis treatment options used to inhibit or treat mucositis. The interventions include

● General Oral Care Protocols

● Interventions To Subdue The Mucosal Toxicity Of Chemotherapy Drugs

● Antiseptics

● Mucosal Barriers And Coating Agents

● Mucosal Cell Stimulants

● Mouthwashes With Mixed Action

● Psychotherapy

● Immunomodulatory Agents

● And Analgesics.

Oral Mucositis Epidemiology Insights

The Oral Mucositis epidemiology division provides insights into historical and current Oral Mucositis patient pools and forecasted trends for every seven significant countries. It helps to identify the causes of the current and forecasted trends by exploring numerous studies and views of key opinion leaders.

Oral Mucositis Market insights

In the coming years, the Oral Mucositis market is estimated to change due to the growing awareness of the disease and incremental healthcare spending across the world; which would expand the oral mucositis market size to permit the drug companies to penetrate more into the oral mucositis market.

Growth of the oral mucositis market is expected to be mainly driven by the increasing cases of cancer cases, expected approval and immediate penetration of emerging therapies, and increase in Research and Development activities.

Major key pharmaceutical players involved in the development of therapies that will drive the Oral Mucositis Market are:

● Galera Therapeutics

● Monopar Therapeutics

● Soligenix

● NeoMedLight

● BrainCool

● MuReva, and others.

About DelveInsight

DelveInsight is a renowned business consulting and market research firm concentrating in the life sciences. It helps pharma companies to improve their production by delivering extensive end-to-end solutions. It also provides Healthcare Consulting Services, which include market analysis and practical solutions for accelerating corporate growth and overcoming problems.